Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-009484

President sold 30,000 shares at an average $62.25 ($1,867,532)

  • President acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
RUBINSTEIN JULIE President 2021-02-08 Option exercise +15,000 $6.32 $94,800 15,000 D
RUBINSTEIN JULIE President 2021-02-08 Sale −10,656 $61.96 $660,246 4,344 D
RUBINSTEIN JULIE President 2021-02-08 Sale −4,344 $62.43 $271,196 0 D
RUBINSTEIN JULIE President 2021-02-09 Option exercise +10,000 $6.55 $65,500 10,000 D
RUBINSTEIN JULIE President 2021-02-09 Option exercise +5,000 $6.32 $31,600 15,000 D
RUBINSTEIN JULIE President 2021-02-09 Sale −7,611 $61.81 $470,436 7,389 D
RUBINSTEIN JULIE President 2021-02-09 Sale −7,389 $63.02 $465,655 0 D
Derivatives
RUBINSTEIN JULIE President 2021-02-08 Option exercise · Stock Option (Right to Buy) −15,000 5,000 D
RUBINSTEIN JULIE President 2021-02-09 Option exercise · Stock Option (Right to Buy) −5,000 0 D
RUBINSTEIN JULIE President 2021-02-09 Option exercise · Stock Option (Right to Buy) −10,000 390,000 D
Open-market sales · 30,000 sh · avg $62.25 · $1,867,532
Loading xslF345X03/doc4.xml…